Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/18316791

J. Clin. Oncol. 2008 Apr 1 26 10 1626-34

Download in:

View as

Triples

General Info

PMID
18316791